Kuros Biosciences AG (SWX:KURN)
17.64
+1.24 (7.56%)
Apr 10, 2025, 5:31 PM CET
Kuros Biosciences AG Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 18.02 | 14.21 | 24.07 | 28.62 | 28.39 | Upgrade
|
Cash & Short-Term Investments | 18.02 | 14.21 | 24.07 | 28.62 | 28.39 | Upgrade
|
Cash Growth | 26.84% | -40.96% | -15.92% | 0.83% | 36.47% | Upgrade
|
Accounts Receivable | 13.4 | 6.41 | 2.82 | 1.69 | 1.04 | Upgrade
|
Other Receivables | 2.75 | 1.21 | 0.8 | 0.36 | 0.37 | Upgrade
|
Receivables | 16.14 | 7.62 | 3.62 | 2.05 | 1.4 | Upgrade
|
Inventory | 9.44 | 4.86 | 3.17 | 1.76 | 1.46 | Upgrade
|
Prepaid Expenses | 1.15 | 0.51 | 0.54 | 0.47 | 0.55 | Upgrade
|
Other Current Assets | - | - | - | - | 2.17 | Upgrade
|
Total Current Assets | 44.75 | 27.19 | 31.39 | 32.89 | 33.97 | Upgrade
|
Property, Plant & Equipment | 3.02 | 2.64 | 2.32 | 2.45 | 2.59 | Upgrade
|
Goodwill | 19.43 | 24.47 | 29.31 | 33.39 | 33.85 | Upgrade
|
Other Intangible Assets | 14.99 | 16.51 | 19.41 | 22.61 | 23.67 | Upgrade
|
Long-Term Deferred Tax Assets | 2.34 | 0.64 | 0.5 | - | 0.3 | Upgrade
|
Other Long-Term Assets | - | 0.01 | - | - | - | Upgrade
|
Total Assets | 84.54 | 71.46 | 82.95 | 91.34 | 94.36 | Upgrade
|
Accounts Payable | 6.91 | 1.3 | 1.3 | 0.85 | 0.94 | Upgrade
|
Accrued Expenses | 13.46 | 7.93 | 5.03 | 3.6 | 2.59 | Upgrade
|
Current Portion of Leases | 0.53 | 0.58 | 0.42 | 0.38 | 0.35 | Upgrade
|
Other Current Liabilities | - | - | 5.84 | 6.46 | - | Upgrade
|
Total Current Liabilities | 20.9 | 9.81 | 12.59 | 11.29 | 3.88 | Upgrade
|
Long-Term Leases | 1.26 | 1.57 | 1.5 | 1.83 | 2.06 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.33 | - | - | 0.89 | 3.24 | Upgrade
|
Other Long-Term Liabilities | 3.16 | 3.38 | - | - | - | Upgrade
|
Total Liabilities | 25.79 | 14.75 | 14.09 | 14.36 | 9.76 | Upgrade
|
Common Stock | 3.79 | 3.68 | 3.66 | 3.28 | 32.81 | Upgrade
|
Additional Paid-In Capital | 73.03 | 73.32 | 160.16 | 154.59 | 125.06 | Upgrade
|
Retained Earnings | -44.45 | -42.15 | -115.83 | -101.59 | -94.27 | Upgrade
|
Treasury Stock | - | -0.02 | -0.02 | -0.02 | -0.02 | Upgrade
|
Comprehensive Income & Other | 26.39 | 21.89 | 20.9 | 20.71 | 21.02 | Upgrade
|
Shareholders' Equity | 58.75 | 56.71 | 68.86 | 76.98 | 84.6 | Upgrade
|
Total Liabilities & Equity | 84.54 | 71.46 | 82.95 | 91.34 | 94.36 | Upgrade
|
Total Debt | 1.79 | 2.14 | 1.91 | 2.21 | 2.41 | Upgrade
|
Net Cash (Debt) | 16.23 | 12.07 | 22.15 | 26.41 | 25.98 | Upgrade
|
Net Cash Growth | 34.51% | -45.53% | -16.12% | 1.66% | 41.45% | Upgrade
|
Net Cash Per Share | 0.44 | 0.33 | 0.65 | 0.81 | 1.07 | Upgrade
|
Filing Date Shares Outstanding | 37.87 | 36.77 | 36.54 | 32.79 | 32.79 | Upgrade
|
Total Common Shares Outstanding | 37.87 | 36.77 | 36.54 | 32.79 | 32.79 | Upgrade
|
Working Capital | 23.86 | 17.38 | 18.8 | 21.6 | 30.09 | Upgrade
|
Book Value Per Share | 1.55 | 1.54 | 1.88 | 2.35 | 2.58 | Upgrade
|
Tangible Book Value | 24.32 | 15.74 | 20.13 | 20.98 | 27.09 | Upgrade
|
Tangible Book Value Per Share | 0.64 | 0.43 | 0.55 | 0.64 | 0.83 | Upgrade
|
Machinery | 2.82 | 1.75 | 1.51 | 1.18 | 0.94 | Upgrade
|
Leasehold Improvements | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.